Biotech Values

[joethdo]

Hi Dew:

I seem to recall posts about TEVA having "labeling discussions" with the FDA which implied potential approval of a non-subsitutable generic. Is that still in play here? Is that a way for the FDA to split the difference in this situation?

Thanks,

Joe